Quantum Biopharma (QNTM) Return on Equity (2024 - 2026)

Quantum Biopharma has disclosed Return on Equity across 3 years of filings, most recently posting 0.04% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.04%, down 3.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.04% (down 3.0% YoY), and the FY2025 annual result was 0.02%, changed N/A from the prior year.
• Return on Equity came in at 0.04% for Q1 2026 at Quantum Biopharma, down from 0.02% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.01% in Q4 2024 to a low of 0.04% in Q1 2026.
• The 3-year median for Return on Equity is 0.02% (2025), against an average of 0.02%.
• Across the five-year window, Return on Equity fell 1 bps in 2025 and slipped 3 bps in 2026, its largest moves.
• Quantum Biopharma's Return on Equity stood at 0.01% in 2024, then plunged by 133 bps to 0.02% in 2025, then tumbled by 101 bps to 0.04% in 2026.
• The last three Return on Equity figures came in at 0.04% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.